Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Appropriate Treatment for Upper Respiratory Infection (URI)

Measure Information
eCQM Compare View

Compare Versions of: "Appropriate Treatment for Upper Respiratory Infection (URI)"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare version to

Table Options
Measure Information 2023 Performance Period 2024 Performance Period 2025 Performance Period 2026 Performance Period
Title Appropriate Treatment for Upper Respiratory Infection (URI) Appropriate Treatment for Upper Respiratory Infection (URI) Appropriate Treatment for Upper Respiratory Infection (URI) Appropriate Treatment for Upper Respiratory Infection (URI)
CMS eCQM ID CMS154v11 CMS154v12 CMS154v13 CMS154v14
CBE ID* Not Applicable Not Applicable Not Applicable Not Applicable
MIPS Quality ID 065 065 065 065
Measure Steward National Committee for Quality Assurance National Committee for Quality Assurance National Committee for Quality Assurance National Committee for Quality Assurance
Description

Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic order

Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic order

Measure Scoring Proportion Proportion Proportion Proportion
Measure Type Process Process Process Process
Stratification *See CMS154v11.html

- 3 months-17 years

- 18-64 years

- 65 years and older

- 3 months-17 years

- 18-64 years

- 65 years and older

Risk Adjustment *See CMS154v11.html

None

None

Rationale *See CMS154v11.html

Most URI, also known as the common cold, are caused by viruses that require no antibiotic treatment. Too often, antibiotics are prescribed inappropriately, which can lead to antibiotic resistance (when antibiotics can no longer cure bacterial infections). In the United States, at least 2.8 million antibiotic-resistant illnesses and 35,000 deaths occur each year (Centers for Disease Control and Prevention [CDC], 2020).

Most URI, also known as the common cold, are caused by viruses that require no antibiotic treatment. Too often, antibiotics are prescribed inappropriately, which can lead to antibiotic resistance (when antibiotics can no longer cure bacterial infections). In the United States, at least 2.8 million antibiotic-resistant illnesses and 35,000 deaths occur each year (Centers for Disease Control and Prevention [CDC], 2020).

Clinical Recommendation Statement *See CMS154v11.html

American Family Physician (Fashner, Ericson, & Werner, 2012)

- Antibiotics should not be used for the treatment of cold symptoms in children or adults. (A)

- Nonsteroidal anti-inflammatory drugs reduce pain secondary to upper respiratory tract infection in adults. (A)

- Decongestants, antihistamine/decongestant combinations, and intranasal ipratropium (Atrovent) may improve cold symptoms in adults. (B)

Institute for Clinical Systems Improvement (ICSI) (Short et al., 2017)

The ICSI work group does not recommend antibiotics for treatment of common cold symptoms in children and adults.

American Family Physician (Fashner, Ericson, & Werner, 2012)

- Antibiotics should not be used for the treatment of cold symptoms in children or adults. (A)

- Nonsteroidal anti-inflammatory drugs reduce pain secondary to upper respiratory tract infection in adults. (A)

- Decongestants, antihistamine/decongestant combinations, and intranasal ipratropium (Atrovent) may improve cold symptoms in adults. (B)

Institute for Clinical Systems Improvement (ICSI) (Short et al., 2017)

The ICSI work group does not recommend antibiotics for treatment of common cold symptoms in children and adults.

Improvement Notation

Higher score indicates better quality

Higher score indicates better quality

Definition *See CMS154v11.html

None

None

Guidance

This is an episode of care measure that examines all eligible episodes for the patient.

This eCQM is an episode-based measure. An episode is defined as each eligible encounter for patients aged 3 months of age and older with a diagnosis of upper respiratory infection from January 1 to December 28 of the measurement period.

 

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

This is an episode of care measure that examines all eligible episodes for the patient.

This eCQM is an episode-based measure. An episode is defined as each eligible encounter for patients aged 3 months of age and older with a diagnosis of upper respiratory infection from January 1 to December 28 of the measurement period.

 

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

Initial Population

Outpatient visits, telephone visits, virtual encounter (i.e., e-visit or virtual check-in), or emergency department visits with a diagnosis of URI from January 1 to December 28 of the measurement period for patients 3 months of age and older

Outpatient visits, telephone visits, virtual encounter (i.e., e-visit or virtual check-in), or emergency department visits with a diagnosis of URI from January 1 to December 28 of the measurement period for patients 3 months of age and older

Denominator

Equals Initial Population

Equals Initial Population

Denominator Exclusions

Exclude URI episodes when the patient had hospice care for any part of the measurement period.

Exclude URI episodes when the patient had a comorbid condition during the 12 months prior to or on the episode date.

Exclude URI episodes where the patient is taking antibiotics in the 30 days prior to the episode date.

Exclude URI episodes where the patient had competing diagnosis on or three days after the episode date.

Exclude URI episodes when the patient had hospice care for any part of the measurement period.

Exclude URI episodes when the patient had a comorbid condition during the 12 months prior to or on the episode date.

Exclude URI episodes where the patient is taking antibiotics in the 30 days prior to the episode date.

Exclude URI episodes where the patient had competing diagnosis on or three days after the episode date.

Numerator

URI episodes without a prescription for antibiotic medication on or three days after the outpatient visit, telephone visit, virtual encounter, or emergency department visit for an upper respiratory infection

URI episodes without a prescription for antibiotic medication on or three days after the outpatient visit, telephone visit, virtual encounter, or emergency department visit for an upper respiratory infection

Numerator Exclusions

Not Applicable

None

Denominator Exceptions

None

None

Telehealth Eligible Yes Yes Yes Yes
Next Version No Version Available
Previous Version No Version Available
Specifications and Data Elements
General eCQM Information
Release Notes
General eCQM Information